Categories
Dr. Lal Path Labs Ltd. — Others, 04-05-2026: Disclosure under SEBI Takeover Regulations
04-05-2026 · 10:54 pm
Dr. Vandana Lal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
No comments yet. Be the first to comment!